FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US, Authority Hl7

17,481 resources

Type: Text:

By Version

 

Start Prev Rows 13200 - 13400 Next

PackageVersionIdentityName/TitleStatusFMMWGDate
fhir.cdc.opioid-cds-r4R4ValueSet/cdc-malignant-cancer-conditionsCDC malignant cancer conditionsactive2023-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.226Opioids, Allactive2024-01
fhir.cdc.opioid-cds-r4R4ValueSet/opioid-analgesics-with-ambulatory-misuse-potentialOpioid analgesics with ambulatory misuse potentialactive2025-02
fhir.cdc.opioid-cds-r4R4ValueSet/extended-release-opioid-with-ambulatory-misuse-potentialExtended release opioid with ambulatory misuse potentialactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1053Carbidopa Levodopa Combination (RXNORM)active2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2362Tuberculosis (Ethambutol) (RXNORM)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2363Tuberculosis (Isoniazid [INH]) (RXNORM)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2364Tuberculosis (Pyrazinamide [PZA]) (RXNORM)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2365Tuberculosis (Rifabutin) (RXNORM)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2366Tuberculosis (Rifampin) (RXNORM)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2367Tuberculosis (Rifapentine) (RXNORM)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.741Hepatitis B Immune Globulin (RXNORM)active2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.747Penicillin G [Benzathine] [Injectable] [Bicillin] (RXNORM)active2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.844Tuberculosis (Second Line Drugs for Treatment) (RXNORM)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.991Rifampin (RXNORM)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1594HIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM)active2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1595HIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM)active2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1597HIV Infection (ARV Combination Treatment for HIV) (RXNORM)active2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1598HIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM)active2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1600HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM)active2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1634Sofosbuvir Velpatasvir Combination (RXNORM)active2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1912Penicillin G [Aqueous Crystalline] [Injectable] (RXNORM)active2023-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1913Penicillin G [Procaine] [Injectable] (RXNORM)active2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1078Opioid Overdose and Poisoning (Naloxone) (RxNorm)active2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1618Smallpox Vaccine (RXNORM)active2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2142Linezolid (RXNORM)active2023-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2143Tuberculosis (Pretomanid) (RXNORM)active2023-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2144Tuberculosis (Bedaquiline) (RXNORM)active2023-01
hl7.fhir.us.davinci-crdR4ValueSet/configTypesCRD Configuration Code Data Types Value Settrial-use4fm2025-08
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-high-dose-rate-technique-vsBrachytherapy High Dose Rate Technique Value Setactive3cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-high-dose-rate-electronic-technique-vsBrachytherapy High Dose Rate Electronic Technique Value Setactive3cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-low-dose-rate-temporary-technique-vsBrachytherapy Low Dose Rate Temporary Radiation Technique Value Setactive3cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-pulsed-dose-rate-technique-vsBrachytherapy Pulsed Dose Rate Technique Value Setactive3cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-permanent-seeds-technique-vsBrachytherapy Permanent Seeds Technique Value Setactive3cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-radiopharmaceutical-technique-vsBrachytherapy Radiopharmaceutical Technique Value Setactive3cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-carbon-ion-beam-technique-vsCarbon Ion Beam Technique Value Setactive3cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-electron-beam-technique-vsElectron Beam Technique Value Setactive3cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-neutron-beam-technique-vsNeutron Beam Technique Value Setactive3cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-photon-beam-technique-vsPhoton Beam Technique Value Setactive3cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-proton-beam-technique-vsProton Beam Technique Value Setactive3cic2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.16Reasons for Interventions Related to Medication Managementactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.558Butalbital analgesicsactive2023-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.789Social Determinants of Health Proceduresactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.790Social Determinants of Health Service Requestsactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.11Food Insecurity Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.118Health Literacy Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.119Health Literacy Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.122Medical Cost Burden Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.123Medical Cost Burden Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.124Health Insurance Coverage Status Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.125Health Insurance Coverage Status Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.20Homelessness Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.21Homelessness Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.226Digital Literacy Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.227Digital Literacy Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.235Digital Access Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.236Digital Access Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.247Utility Insecurity Proceduresactive2024-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.252Utility Insecurity Service Requestsactive2024-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.260Incarceration Status Proceduresactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.261Incarceration Status Service Requestsactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.268Language Access Proceduresactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.269Language Access Service Requestsactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.27Transportation Insecurity Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.28Transportation Insecurity Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.31Financial Insecurity Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.32Financial Insecurity Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.38Material Hardship Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.39Material Hardship Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.44Housing Instability Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.45Housing Instability Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.52Inadequate Housing Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.53Inadequate Housing Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.56Less Than High School Education Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.57Less Than High School Education Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.59Unemployment Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.60Unemployment Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.67Elder Abuse Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.68Elder Abuse Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.7Food Insecurity Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.87Stress Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.90Veteran Status Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.91Veteran Status Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.92Stress Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.94Social Connection Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.95Social Connection Service Requestsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.97Intimate Partner Violence Proceduresactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.98Intimate Partner Violence Service Requestsactive2024-06
fhir.cdc.opioid-cds-r4R4ValueSet/amphetamines-class-medicationsAmphetamine class medicationsactive2025-02
hl7.fhir.us.covid19libraryR4ValueSet/covid-19-severity-value-setCOVID-19 Signs and Symptoms Severity Value Setactive2022-07
hl7.fhir.us.breastcancerR3ValueSet/oncology-TumorMarginDescriptionVSBC TumorMarginDescriptionVS ValueSetdraft2018-08
hl7.fhir.us.breastcancerR3ValueSet/oncology-Ki-67NuclearAntigenVSBC Ki-67NuclearAntigenVS ValueSetdraft2018-08
signal.core.r4R4ValueSet/servicerequest-orderdetailService Request Order Details Codesdraft1oo2019-10
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.22.5.306Infectious Diseaseactive2024-06
hl7.fhir.us.breastcancerR3ValueSet/cimi-element-AnatomicalDirectionVSBC AnatomicalDirectionVS ValueSetdraft2018-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.21Annual Physical CPT CN5active2023-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.23Annual Physical CPT for Tax Pair CN5active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.30Annual Physical Codes for Tax Pair CN5active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.22Annual Physical HCPCS CN5active2023-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.17Annual Physical ICD10 CN5active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.16Annual Physical ICD9 CN5active2023-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.24Annual Physical ICD9 for Tax Pair CN5active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.18Annual Physical SNOMED CN5active2023-04
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.19Annual Physical Taxonomy CN5active2024-06
hl7.fhir.us.breast-radiologyR4ValueSet/rde1559-depthRDE1559 Depthdraft2022-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.45Endometrial Cancer ICD9active2023-11
fhir.cdc.opioid-cds-r4R4ValueSet/conditions-documenting-substance-misuseConditions documenting substance misuseactive2025-04
hl7.fhir.us.codex-radiation-therapyR4ValueSet/codexrt-brachytherapy-applicator-type-vsBrachytherapy Applicator Type Value Setactivecgp2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.20.2.7Nutritional Statusactive2025-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.326Arboviral Disease [Other] (Disorders) (ICD10CM)active2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.575Arboviral Disease [Other] (Tests for Arbovirus [Other] Nucleic Acid)active2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.576Arboviral Disease [Other] (Tests for Arbovirus [Other] Antigen)active2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.577Arboviral Disease [Other] (Tests for Arbovirus [Other] IgM Antibody)active2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.578Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Quantitative])active2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.579Arboviral Disease [Other] (Tests for Arbovirus [Other] Antibody [Qualitative])active2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.580Arboviral Disease [Other] (Organism or Substance in Lab Results)active2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.963Arboviral Disease [Other] (Disorders) (SNOMED)active2025-02
hl7.fhir.us.registry-protocolsR4ValueSet/ArterialAccessSiteArterial Access Siteactivecic2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1186.7Common substances for allergy and intolerance documentationactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1186.8Common substances for allergy and intolerance documentation including refutationsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1115.39Personal Health Goal Options Groupingactive2025-03
ca.on.dhdr.r4.v4R4ValueSet/drug-service-coverageDrug Service Coverageactive
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.80.60Social History Type (SCT)active2025-04
hl7.fhir.us.ndhR4ValueSet/NdhAssociatedServersTypeVSAssociated Servers Type Value Settrial-usepa2025-07
hl7.fhir.us.breast-radiologyR4ValueSet/AsymmetryAbnormalityTypeVSAsymmetry Abnormality Type ValueSetactive2022-12
fhir.ca-bc.clientR4ValueSet/bc-address-validation-value-setBC Address Validation Value Setactive2025-02
fhir.ca-bc.clientR4ValueSet/bc-contact-point-system-value-setBC Contact Point System Value Setactive2025-02
fhir.ca-bc.clientR4ValueSet/bc-contact-point-use-value-setBC Contact Point Use Value Setactive2025-02
fhir.ca-bc.providerR4ValueSet/bc-expertise-value-setBC Expertise Value Setactive2025-02
fhir.ca-bc.clientR4ValueSet/bc-identifier-status-value-setBC Identifier Status Value Setactive2025-02
fhir.ca-bc.providerR4ValueSet/bc-language-value-setBC Language Value Setactive2025-02
fhir.ca-bc.clientR4ValueSet/bc-merge-status-value-setBC Merge Status Value Setactive2025-02
fhir.ca-bc.clientR4ValueSet/bc-name-use-value-setBC Name Use value set.active2025-02
fhir.ca-bc.providerR4ValueSet/bc-organization-role-value-setBC Organization Role Code Value Setactive2025-02
fhir.ca-bc.providerR4ValueSet/bc-practitioner-role-value-setBC Practitioner Role Code Value Setactive2025-02
fhir.ca-bc.providerR4ValueSet/bc-address-validation-status-value-setBC Address Validation Status Value Setactive2025-02
fhir.ca-bc.providerR4ValueSet/bc-communication-purpose-value-setBC Communication Purpose Value Setactive2025-02
fhir.ca-bc.providerR4ValueSet/bc-end-reason-value-setBC End Reason Value Setactive2025-02
fhir.ca-bc.providerR4ValueSet/bc-relationship-type-value-setBC Relationship Type Value Setactive2025-02
fhir.ca-bc.providerR4ValueSet/bc-license-status-class-value-setBC License Status Class Value Setactive2025-02
fhir.ca-bc.providerR4ValueSet/bc-license-status-reason-value-setBC License Status Reason Value Setactive2025-02
fhir.ca-bc.providerR4ValueSet/bc-license-status-value-setBC License Status Value Setactive2025-02
fhir.ca-bc.providerR4ValueSet/bc-qualification-value-setBC Practitioner Qualification Value Setactive2025-02
hl7.fhir.us.bserR4ValueSet/TaskBusinessStatusVSTask Business Status VSdraft2025-04
hl7.fhir.us.davinci-drug-formularyR4ValueSet/BenefitCostTypeVSBenefit type of costtrial-usephx2025-02
fhir.giisR4ValueSet/BirthplaceVSBirthplacedraft2025-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1237.18Medication Prescribable Brand Nameactive2021-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.80.16Medication Brand Nameactive2024-06
hl7.fhir.us.breast-radiologyR4ValueSet/BreastAssessmentCategoryVSBreast Assessment Category ValueSetactive2022-12
hl7.fhir.us.breast-radiologyR4ValueSet/rde1560-breast-body-landmarkRDE1560 Breast body landmarkdraft2022-12
hl7.fhir.us.breast-radiologyR4ValueSet/rde1557-sideRDE1557 Sidedraft2022-12
hl7.fhir.us.directory-queryR4ValueSet/HealthcareServiceCategoryVSHealthcare Service Category Value Setactive2022-12
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/HealthcareServiceCategoryVSHealthcare Service CategoryVStrial-usefm2025-02
hl7.fhir.us.ndhR4ValueSet/HealthcareServiceCategoryVSHealthcare Service Category Value Settrial-usepa2025-07
signal.core.r4R4ValueSet/signal-healthcare-service-categorySignal Healthcare Service Categorydraft1pa
fhir.cdc.opioid-cds-r4R4ValueSet/opioid-treatment-assessment-procedureOpioid treatment assessment procedureactive2023-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1010.1Substance Reactant for Intoleranceactive2024-06
hl7.fhir.us.mcodeR4ValueSet/mcode-lymphoma-stage-bulky-modifier-vsLymphoma Stage Bulky Modifier Value Setactivecic2025-02
hl7.fhir.us.vdorR4ValueSet/vdor-bystanders-present-vsVDOR Bystander(s) Presentinformativepher2025-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.3221.8.11Medication Product Formactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.114Hematocrit Lab Testactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.117Potassium Lab Testactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.119Sodium Lab Testactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.127Platelet Count Lab Testactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.129White Blood Cells Count Lab Testactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.134Glucose Lab Testactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.139Bicarbonate Lab Testactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.152Body Temperatureactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.159Body Weightactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1104.10Medicare FFS Payeractive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1104.12Medicare Advantage Payeractive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.2363Creatinine Lab Testactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.151Oxygen Saturation by Pulse Oximetryactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.36All Metastatic Sitesactive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.43Breast Canceractive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.44Breast Canceractive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.15All Metastatic Sitesactive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.35All Metastatic Sitesactive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.39Locoregional Breast Canceractive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.38Locoregional Breast Canceractive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.37Locoregional Breast Canceractive2023-10
hl7.fhir.us.davinci-pctR4ValueSet/PCTGFECMSPOSPCT GFE CMS Place of Service Value Settrial-usefm2025-08
signal.core.r4R4ValueSet/place-of-servicePlace Of Servicedraft1pa
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.229COVID19 Related Disease, Test, or Exposureactive2021-03
hl7.fhir.us.davinci-pctR4ValueSet/USClaimMedicalProductOrServiceCodesClaim Medical Product or Service Value Settrial-usefm2025-08
hl7.fhir.us.davinci-pctR4ValueSet/PCTGFEItemCptHcpcsVSPCT GFE Item CPT - HCPCS Value Settrial-usefm2025-08
hl7.fhir.us.icsr-ae-reportingR4ValueSet/COVID19VaccineCodeVSCOVID-19 Vaccine Codesdraft2023-08
hl7.fhir.us.registry-protocolsR4ValueSet/CardiacCTACTA Heart and Coronary arteriesactivecic2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.80.22CVX Vaccines Administered Complete Setactive2024-06
hl7.fhir.us.icsr-ae-reportingR4ValueSet/VaccineCodeVSVaccine Codesdraft2023-08
hl7.fhir.us.icsr-ae-reportingR4ValueSet/InfluenzaVaccineCodeVSInfluenza Vaccine Codesdraft2023-08
hl7.fhir.us.breast-radiologyR4ValueSet/CalcificationDistributionVSCalcificationDistribution ValueSetactive2022-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1189California Serogroup Virus Diseases (Tests for California Serogroup Virus Antibody [Qualitative])active2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.16All Metastatic Sitesactive2023-10
fhir.cdc.opioid-cds-r4R4ValueSet/cannabinoid-urine-drug-screening-testsCannabinoid class urine drug screeningactive2023-05
hl7.fhir.us.registry-protocolsR4ValueSet/CardiacCTAResultsCardiac CTA Resultsactivecic2023-11
hl7.fhir.us.registry-protocolsR4ValueSet/CardiacInstabilityTypeCardiac Instability Typeactivecic2023-11
hl7.fhir.us.pcoR4ValueSet/pco-categoriesPerson-Centered Categoriesdraft2pc2025-08
hl7.fhir.us.directory-queryR4ValueSet/OrgAliasTypeVSOrganization Alias Typ Value Seteactive2022-12
hl7.fhir.us.ndhR4ValueSet/OrgAliasTypeVSOrganization Alias Type Value Setetrial-usepa2025-07